Target intelligence / Profile preview

Volar fibroblast–keratinocyte signaling pathways

Molecular classification
Other
01

Overview

The volar fibroblast–keratinocyte signaling pathway is a specialized paracrine communication system that determines the unique physiological characteristics of glabrous (non-hairy) skin found on the palms and soles (Yamaguchi et al., 2004, J Cell Sci). This pathway is primarily driven by the secretion of Dickkopf-1 (DKK1) by volar dermal fibroblasts, which acts as a potent antagonist of the Wnt/beta-catenin signaling pathway in overlying keratinocytes (Yamaguchi et al., 2008, Gene). The suppression of Wnt signaling in these keratinocytes induces the expression of volar-specific markers, such as Keratin 9 (KRT9), and results in a thickened stratum corneum and the absence of hair follicles (Rognoni et al., 2016, Exp Dermatol). Dysregulation of this signaling axis is implicated in various skin disorders, including palmoplantar keratodermas and the site-specific development of acral lentiginous melanoma (Choi et al., 2014, J Invest Dermatol). While not a single drug target, components of this pathway, particularly DKK1 and the Wnt signaling cascade, are being explored for therapeutic intervention in wound healing and oncology (DKN-01 clinical trials). This signaling network highlights the importance of mesenchymal-epithelial interactions in maintaining tissue-specific identity and homeostasis.

Other names
Palmoplantar fibroblast-keratinocyte crosstalkDKK1-Wnt signaling axis in skinGlabrous skin signaling pathway
02

Mechanism of action

Modulation of the Wnt/beta-catenin pathway via DKK1 secretion from dermal fibroblasts to influence keratinocyte differentiation and regional skin identity.

03

Biological functions

Signal transductionCell differentiationSkin developmentEpithelial-mesenchymal interaction
04

Disease associations

Palmoplantar keratodermaCancerOther
05

Safety considerations

Off-target Wnt signaling effectsBone density changesGastrointestinal toxicityPotential for impaired wound healing in non-volar tissues
06

Interacting drugs

DKN-01

1 more in the full profile.

07

Biomarkers

Dickkopf-1 (DKK1)Keratin 9 (KRT9)Keratin 14 (KRT14)

Beyond the preview

Go deeper on Volar fibroblast–keratinocyte signaling pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Volar fibroblast–keratinocyte signaling pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call